Bionomics has announced the final results of its Phase Ia clinical trial of BNC210. The primary objectives of the trial, to evaluate the safety, tolerability and the pharmacokinetics of the drug were ....
ERT has announced its Knowledge Series of educational papers. Each paper discusses issues that are relevant to patient safety in clinical trials today. The paper that is written by Michael Federico, investigates ....
Aegera Therapeutics has announced the successful completion of a dose-ranging Phase 1 study and the initiation of a randomized Phase 2 study of AEG35156. This is in combination with sorafenib for the ....
Bayer Schering Pharma has held two investigators meetings in Beijing, China and Seoul, Korea to announce the start of ADVISE, the Asia Pacific trial - nifeDipine in combination with Valsartan to achIeve ....
The Society for Clinical Data Management (SCDM) has published Edit Check Design Principles, a collection of best practices for the creation of edit checks - a key tool for efficiency and data quality. ....
BiondVax Pharmaceuticals, an Israeli biopharmaceutical company, has announced the success of the Phase I/II clinical trial of the company's Multimeric-001 universal flu vaccine, in trials that were conducted ....
China Aoxing Pharmaceutical Company, a pharmaceutical company specializing in the research, development, manufacturing and distribution of narcotic and pain-management products, has announced that it ....
Sinovac Biotech, a provider of biopharmaceutical products in China, has filed an application with China's State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against ....
PPD has entered into an exclusive alliance with DiabetesAmerica, a provider of diabetes care services based in Houston, Texas. Under the agreement, the former will provide clinical research training and ....
Siinovac Biotech, a provider of biopharmaceutical products in China, has filed the application with China's State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine ....